首页> International journal of clinical oncology> Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer

Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer

导出原文传递

翻译打印收藏纠错

第一作者： Wang, Ji

作者： Wang, Ji ^[1] ; Wang, Xinyang ; Chen, Rui ; Liang, Mengdi ; Li, Minghui ; Ma, Ge ; Xia, Tiansong ; Wang, Shui

作者单位： Affiliated Hosp 1,Nanjing Med Univ ^[1]

关键词 Breast neoplasms Neoadjuvant therapy Neoplastic cells Circulating Response evaluation criteria in solid tumors Treatment outcome SURVIVAL THERAPY TRASTUZUMAB

发布时间 2023-01-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

International journal of clinical oncology

2022年27卷5期

889-898页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

International journal of clinical oncology

2022年27卷5期

889-898页

检索历史清除

Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer

International journal of clinical oncology

相似文献

同项目论文

International journal of clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer

International journal of clinical oncology

相似文献

同项目论文

International journal of clinical oncology

相关期刊

检索历史清除